SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yaseen M. Arabi, Saqib I. Dara, Ziad Memish, Abdulmajeed Al Abdulkareem, Hani M. Tamim, Nehad Al-Shirawi, Joseph E. Parrillo, Peter Dodek, Stephen Lapinsky, Daniel Feinstein, Gordon Wood, Sandra Dial, Sergio Zanotti, Anand Kumar, Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis, Hepatology, 2012, 56, 6
  2. 2
    Vasiliki Arvaniti, Gennaro D'Amico, Giuseppe Fede, Pinelopi Manousou, Emmanuel Tsochatzis, Maria Pleguezuelo, Andrew Kenneth Burroughs, Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis, Gastroenterology, 2010, 139, 4, 1246

    CrossRef

  3. 3
    Claire Francoz, Denis Glotz, Richard Moreau, François Durand, The evaluation of renal function and disease in patients with cirrhosis, Journal of Hepatology, 2010, 52, 4, 605

    CrossRef

  4. 4
    Erica Horinek, Doug Fish, Spontaneous Bacterial Peritonitis, AACN Advanced Critical Care, 2009, 20, 2, 121

    CrossRef

  5. 5
    P.A. McCormick, Carmel Donnelly, Management of hepatorenal syndrome, Pharmacology & Therapeutics, 2008, 119, 1, 1

    CrossRef

  6. 6
    Zvi Ackerman, Fanny Karmeli, Galina Pizov, Iddo Ben-Dov, Orit Pappo, Renal Effects of Gentamicin in Chronic Bile Duct Ligated Rats, Digestive Diseases and Sciences, 2006, 51, 2, 406

    CrossRef

  7. 7
    P. ANGELI, S. GUARDA, S. FASOLATO, E. MIOLA, R. CRAIGHERO, F. PICCOLO, C. ANTONA, L. BROLLO, M. FRANCHIN, U. CILLO, C. MERKEL, A. GATTA, Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost, Alimentary Pharmacology & Therapeutics, 2006, 23, 1
  8. 8
    Ying-Ying Yang, Han-Chieh Lin, Bacterial Infections in Patients with Cirrhosis, Journal of the Chinese Medical Association, 2005, 68, 10, 447

    CrossRef

  9. 9
    Ioannis A. Bliziotis, George Samonis, Konstantinos Z. Vardakas, Stavroula Chrysanthopoulou, Matthew E. Falagas, Effect of Aminoglycoside and β-Lactam Combination Therapy versus β-Lactam Monotherapy on the Emergence of Antimicrobial Resistance: A Meta-analysis of Randomized, Controlled Trials, Clinical Infectious Diseases, 2005, 41, 2, 149

    CrossRef

  10. 10
    Pierre-Yves Bochud, Marc Bonten, Oscar Marchetti, Thierry Calandra, Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review, Critical Care Medicine, 2004, 32, Supplement, S495

    CrossRef

  11. 11
    Jean-Didier Grangé, Comment traiter et prévenir l’infection du liquide d’ascite ?, Gastroentérologie Clinique et Biologique, 2004, 28, 278

    CrossRef

  12. 12
    J D Grang??, X Amiot, Nitric oxide and renal function in cirrhotic patients with ascites, European Journal of Gastroenterology & Hepatology, 2004, 16, 6, 567

    CrossRef

  13. 13
    Carine Chagneau, Traitement et prévention de l’infection du liquide d’ascite, Gastroentérologie Clinique et Biologique, 2004, 28, 138

    CrossRef

  14. 14
    Xavier Amiot, Jean-Didier Grange, Re: Hempel et al.-risk factors for renal dysfunction in hospitalized cirrhotic patients, The American Journal of Gastroenterology, 2002, 97, 5, 1263

    CrossRef

  15. 15
    M. Borzio, F. Salerno, L. Piantoni, M. Cazzaniga, P. Angeli, F. Bissoli, S. Boccia, G. Colloredo-Mels, P. Corigliano, G. Fornaciari, G. Marenco, R. Pistarà, M. Salvagnini, A. Sangiovanni, Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study, Digestive and Liver Disease, 2001, 33, 1, 41

    CrossRef

  16. 16
    Suchat Wongcharatrawee, Guadalupe Garcia-Tsao, CLINICAL MANAGEMENT OF ASCITES AND ITS COMPLICATIONS, Clinics in Liver Disease, 2001, 5, 3, 833

    CrossRef

  17. 17
    M. Navasa, F. Casafont, G. Clemente, C. Guarner, M. de la Mata, R. Planas, R. Solà, J. Suh, Consenso sobre peritonitis bacteriana espontánea en la cirrosis hepática: diagnóstico, tratamiento y profilaxis, Gastroenterología y Hepatología, 2001, 24, 1, 37

    CrossRef

  18. 18
    Elena Ricart, Germán Soriano, Maria Teresa Novella, Jordi Ortiz, Míriam Sàbat, Lylian Kolle, Javier Sola-Vera, Josep Miñana, Josep Maria Dedéu, Cristina Gómez, José L Barrio, Carlos Guarner, Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients, Journal of Hepatology, 2000, 32, 4, 596

    CrossRef

  19. 19
    Antoni Rimola, Guadalupe García-Tsao, Miquel Navasa, Laura J.V. Piddock, Ramon Planas, Brigitte Bernard, John M. Inadomi, Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document, Journal of Hepatology, 2000, 32, 1, 142

    CrossRef

  20. 20
    Norberto C Chavez-Tapia, Karla Soares-Weiser, Mayer Brezis, Leonard Leibovici, Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients, The Cochrane Library,
  21. 21
    K Soares-Weiser, M Brezis, L Leibovici, Antibiotics for spontaneous bacterial peritonitis in cirrhotics, The Cochrane Library,
  22. 22
    Mical Paul, Simona Grozinsky-Glasberg, Karla Soares-Weiser, Leonard Leibovici, Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis, The Cochrane Library,
  23. You have free access to this content23
    Mical Paul, Adi Lador, Simona Grozinsky-Glasberg, Leonard Leibovici, Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis, The Cochrane Library,